BioNTech SE (BNTX) EBT Growth (1y) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.59% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -148.28% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -313.33% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 71.54% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -79.57% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.15% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 9,460.35% |
| 10 | BioNTech SE | 27.66 Bn | 7.53 Bn | 668.28 Mn | -182.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -182.24% |
| Sep 30, 2025 | -83.43% |
| Jun 30, 2025 | 47.47% |
| Mar 31, 2025 | -29.98% |
| Dec 31, 2024 | -54.89% |
| Sep 30, 2024 | -29.59% |
| Jun 30, 2024 | -93.33% |
| Mar 31, 2024 | -147.45% |
| Dec 31, 2023 | -77.95% |
| Sep 30, 2023 | -89.95% |
| Jun 30, 2023 | -118.14% |
| Mar 31, 2023 | -86.51% |
| Dec 31, 2022 | -39.98% |
| Sep 30, 2022 | -55.23% |
| Jun 30, 2022 | -48.92% |
| Mar 31, 2022 | 184.30% |
| Dec 31, 2021 | 2,199,836,406.41% |
| Sep 30, 2021 | 2,170.94% |
| Jun 30, 2021 | 4,759.99% |
| Mar 31, 2021 | 3,260.46% |
| Dec 31, 2020 | 100.10% |
| Sep 30, 2020 | 623.78% |
| Jun 30, 2020 | 77.18% |
| Mar 31, 2020 | 27.26% |
| Dec 31, 2019 | 99.55% |
| Sep 30, 2019 | 25.69% |